Tag Archive for: stroke treatment

Posts

A tough clot: platelet-rich thrombi and efficacy of endovascular therapy

27/07/2022

https://eso-stroke.org/wp-content/uploads/esoa_7_2.cover_.png 900 694 Michele Schaub Jackson https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Michele Schaub Jackson2022-07-27 16:02:002022-07-27 16:02:00A tough clot: platelet-rich thrombi and efficacy of endovascular therapy

Thrombectomy vs. thrombectomy plus intravenous alteplase – Full results of SWIFT DIRECT and DIRECT-SAFE

11/07/2022

https://eso-stroke.org/wp-content/uploads/SVIN-ABBA-Survey-20220228.png 381 532 Meaghan Dreyer https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Meaghan Dreyer2022-07-11 11:05:452022-07-11 11:05:45Thrombectomy vs. thrombectomy plus intravenous alteplase – Full results of SWIFT DIRECT and DIRECT-SAFE

Heart and brain: Is there a role for cardiac biomarkers in acute stroke treatment and prognosis?

08/07/2022

https://eso-stroke.org/wp-content/uploads/13529672-bpinfoHW.jpeg 575 940 Michele Schaub Jackson https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Michele Schaub Jackson2022-07-08 13:00:222022-07-01 16:48:11Heart and brain: Is there a role for cardiac biomarkers in acute stroke treatment and prognosis?

Is blood pressure variability associated with functional outcome after EVT?

01/07/2022

https://eso-stroke.org/wp-content/uploads/esoa_7_2.cover_.png 900 694 Michele Schaub Jackson https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Michele Schaub Jackson2022-07-01 15:30:232022-07-01 15:46:18Is blood pressure variability associated with functional outcome after EVT?

The ESJ factor turned 5.894!

29/06/2022

https://eso-stroke.org/wp-content/uploads/ESO-ESJ-Impact-Factor.png 1356 1904 Carine Legio https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Carine Legio2022-06-29 15:36:302022-06-29 15:45:36The ESJ factor turned 5.894!

Cerebral venous thrombosis, HIT and VITT: from antibodies to management

25/06/2022

https://eso-stroke.org/wp-content/uploads/SVIN-ABBA-Survey-20220228.png 381 532 Michele Schaub Jackson https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Michele Schaub Jackson2022-06-25 14:10:292022-06-25 14:10:29Cerebral venous thrombosis, HIT and VITT: from antibodies to management

The power of translational research for acute ischemic stroke

https://eso-stroke.org/wp-content/uploads/Figure-ESO-Blog.jpg 613 1790 Carine Legio https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Carine Legio2022-06-17 13:33:122022-06-17 17:02:14The power of translational research for acute ischemic stroke

Intravenous thrombolysis with tenecteplase 0.25mg/kg moving forward: insights from ESOC 2022

https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png 0 0 Michele Schaub Jackson https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Michele Schaub Jackson2022-06-10 10:12:092022-06-10 14:10:43Intravenous thrombolysis with tenecteplase 0.25mg/kg moving forward: insights from ESOC 2022

Reflections from the European Stroke Organisation Conference 2022

https://eso-stroke.org/wp-content/uploads/SS16_ESC_ESO_SYMP_HD-scaled.jpg 1707 2560 Lara Le Noan https://eso-stroke.org/wp-content/uploads/ESO-Horiz-mit-Schutzraum.png Lara Le Noan2022-05-20 13:14:192022-05-24 11:44:01Reflections from the European Stroke Organisation Conference 2022